Rep. Kevin Hern (R-OK) Sells IQVIA (IQV) Stock

Oklahoma Congressman Kevin Hern sold shares of IQVIA Holdings Inc. (NYSE: IQV) on September 8, 2026. The transaction was valued between $1,001 and $15,000, with the stock priced at $270.45 at the time of the sale. This sale adds to Hern's recent trading activity; he also sold shares in Rockwell Automation and NextEra Energy earlier this month.

Inside Kevin Hern's Trade

Hern's sale reflects his ongoing process of managing investments while serving in Congress. This transaction was reported on September 25, 2026, and is part of his broader investment strategy. As a Republican representative for Oklahoma's 1st district, his financial activities may draw interest given the constituent focus on economic issues.

Other Institutional Activity in IQVIA Holdings

Several institutional investors made notable moves with IQVIA Holdings recently. Blackrock Inc. trimmed its stake by 477,877 shares, ending with 14,549,693 shares worth about $3.85 billion. Vanguard Capital Management LLC also reduced its position, selling 122,405 shares for a total of 10,905,053 shares valued at approximately $2.88 billion. Meanwhile, State Street Corporation added 31,403 shares, bringing its total to 7,508,244 shares worth about $1.98 billion.

IQVIA Holdings Inc. Stock Up 1.5%

As of the publication on Friday, IQVIA shares traded at $270.45, sitting close to the 52-week high of $273.88. The stock is well above its 200-day moving average of $203.85, reflecting strong investor interest and a solid performance over the past year.

Recent Earnings

In its latest earnings report, IQVIA posted a revenue of about $16.98 billion, showing a revenue growth of 8.7%. The company's EPS stands at $8.05, and it has a net margin of 8.1%. The next earnings date is set for November 3, 2026, which could provide more insights into its financial health.

Analysts Set New Price Targets

On September 29, 2026, RBC Capital maintained its outperform rating for IQVIA, setting a new price target at $319. Earlier, on October 7, Mizuho and Barclays also maintained their ratings, both with price targets of $300. The consensus recommendation across 18 analysts remains a strong buy, with a mean price target of $277.94.

About IQVIA Holdings Inc.

IQVIA Holdings Inc. provides essential services in clinical research and healthcare intelligence. Operating globally, it focuses on improving outcomes in the life sciences and healthcare sectors. This makes it a critical player in the industry, especially as healthcare continues to evolve with technology advancements.

Bottom Line

Investors will be watching IQVIA closely as it approaches its earnings report on November 3, 2026. Kevin Hern's recent stock sale is part of a broader pattern of trades that reflect his ongoing management of personal investments while in office. As always, the 13F filing reveals past positions and may not reflect current holdings.